Clonidine as an adjuvant for propranolol enhances its effect on infiltrative cutaneous analgesia in rats

doi:10.1016/j.neulet.2016.01.054

CNU IR > Pharmacy and Science > Dept. of Pharmacy > Periodical Articles > Item 310902800/30973

Please use this identifier to cite or link to this item: https://ir.cnu.edu.tw/handle/310902800/30973

Title:	Clonidine as an adjuvant for propranolol enhances its effect on infiltrative cutaneous analgesia in rats
Authors:	Hung, Ching-Hsia Chiu, Chong-Chi Liu, Kuo-Sheng Wang, Jhi-Joung Chen, Yu-Wen
Contributors:	Natl Cheng Kung Univ, Coll Med, Dept Phys Therapy Natl Cheng Kung Univ, Coll Med, Inst Allied Hlth Sci Chi Mei Med Ctr, Dept Gen Surg Chi Mei Med Ctr, Dept Gen Surg Southern Taiwan Univ Sci & Technol, Dept Elect Engn Chia Nan Univ Pharm & Sci, Dept Pharm Chi Mei Med Ctr, Dept Med Res China Med Univ, Coll Hlth Care, Dept Phys Therapy
Keywords:	Clonidine Adjuvant Propranolol Bupivacaine Subcutaneous injection Infiltrative cutaneous analgesia lidocaine
Date:	2016-03
Issue Date:	2018-01-18 11:39:01 (UTC+8)
Publisher:	Elsevier Ireland Ltd
Abstract:	Clonidine prolongs duration of analgesia when used as an adjunct to local anesthetics for infiltrative cutaneous analgesia, and propranolol produces local anesthesia. The purpose of the experiment was to evaluate clonidine as an adjuvant for propranolol on the quality and duration of cutaneous analgesia. A rat model of cutaneous trunci muscle reflex (CTMR) in response to local skin pinprick was employed to evaluate the cutaneous analgesic effect of propranolol combined with clonidine. The long-lasting local anesthetic bupivacaine was used as control. Cutaneous analgesia elicited by propranolol and bupivacaine was dose-dependent, and both propranolol (9.0 mu mol) and bupivacaine (1.8 mu mol) produced 100% nociceptive blockade. On an 50% effective dose (ED50) basis, the relative potency was bupivacaine [0.48 (0.42-0.55) mu mol] greater than propranolol [2.27 (1.98-2.54) mu mol] (p < 0.01). Subcutaneous saline and clonidine (0.12 mu mol) did not produce cutaneous analgesia. The mixture of an ineffective-dose clonidine (0.12 mu mol) and a drug (propranolol or bupivacaine) at ED50 or ED95 increased the potency and extended the duration at producing cutaneous analgesia. The resulting data demonstrated that propranolol is less potent than bupivacaine as an infiltrative anesthetic. Clonidine as an adjuvant for propranolol or bupivacaine has a significant peripheral action in increasing the depth and duration of action on infiltrative cutaneous analgesia. (C) 2016 Elsevier Ireland Ltd. All rights reserved.
Relation:	Neuroscience Letters, v.616, pp.70-74
Appears in Collections:	[Dept. of Pharmacy] Periodical Articles

Files in This Item:

File	Description	Size	Format
index.html		0Kb	HTML	1249	View/Open

Loading...